ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

MennatAllah Shaheen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5041-4218; OpenAlex author ID A5053159735. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2026: 1 paper

Papers 1

The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/2767-9764.crc-25-0278 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ching-Fei Li · 1 shared paper, 2026 · strength 0.27
- Paper The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenoca… DOI 10.1158/2767-9764.crc-25-0278 ↗
Benson Chellakkan Selvanesan · 1 shared paper, 2026 · strength 0.27
- Paper The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenoca… DOI 10.1158/2767-9764.crc-25-0278 ↗
Huamin Wang · 1 shared paper, 2026 · strength 0.27
- Paper The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenoca… DOI 10.1158/2767-9764.crc-25-0278 ↗
Haoqiang Ying · 1 shared paper, 2026 · strength 0.27
- Paper The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenoca… DOI 10.1158/2767-9764.crc-25-0278 ↗
Anirban Maitra · 1 shared paper, 2026 · strength 0.27
- Paper The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenoca… DOI 10.1158/2767-9764.crc-25-0278 ↗
Bidyut Ghosh · 1 shared paper, 2026 · strength 0.27
- Paper The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenoca… DOI 10.1158/2767-9764.crc-25-0278 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.